Pharmacyte Biotech Stock Statistic Functions Beta
| PMCB Stock | USD 0.78 0.04 5.41% |
| Symbol |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on PharmaCyte Biotech correlated with the market. If Beta is less than 0 PharmaCyte Biotech generally moves in the opposite direction as compared to the market. If PharmaCyte Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PharmaCyte Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PharmaCyte Biotech is generally in the same direction as the market. If Beta > 1 PharmaCyte Biotech moves generally in the same direction as, but more than the movement of the benchmark.
PharmaCyte Biotech Technical Analysis Modules
Most technical analysis of PharmaCyte Biotech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PharmaCyte from various momentum indicators to cycle indicators. When you analyze PharmaCyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PharmaCyte Biotech Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PharmaCyte Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of PharmaCyte Biotech based on widely used predictive technical indicators. In general, we focus on analyzing PharmaCyte Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PharmaCyte Biotech's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of PharmaCyte Biotech's intrinsic value. In addition to deriving basic predictive indicators for PharmaCyte Biotech, we also check how macroeconomic factors affect PharmaCyte Biotech price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2011 | 2025 (projected) | Dividend Yield | 0.12 | 0.11 | Price To Sales Ratio | 215.39 | 3.2K |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PharmaCyte Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PharmaCyte Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PharmaCyte Biotech. Anticipated expansion of PharmaCyte directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive PharmaCyte Biotech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding PharmaCyte Biotech requires distinguishing between market price and book value, where the latter reflects PharmaCyte's accounting equity. The concept of intrinsic value - what PharmaCyte Biotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push PharmaCyte Biotech's price substantially above or below its fundamental value.
It's important to distinguish between PharmaCyte Biotech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PharmaCyte Biotech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PharmaCyte Biotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.